May 13, 2025-- GE HealthCare recently announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company’s Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) ultrasound enhancing agent (UEA). This approval will help improve the clarity and diagnostic accuracy of echocardiograms in pediatric patients, giving cardiologists a fuller picture of ventricular function when assessing possible heart abnormalities or disease. 

May 19, 2025 - Arineta, a provider of cardiovascular imaging solutions, recently announced that its SpotLight Duo cardiac CT scanner has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for low-dose lung cancer screening (LDCT). This clearance allows providers to use a single ultra-fast CT platform for both cardiac and lung imaging and diagnostics, delivering more complete care to high-risk patients.

May 15, 2025 – Royal Philips, a global leader in health technology, has released its 10th annual Future Health Index (FHI) report, highlighting the growing strain on global healthcare systems. The FHI 2025 Report, the largest global survey of its kind analyzing key concerns of healthcare professionals and patients, indicates AI holds promise for transforming care delivery.

May 15, 2025 – Shockwave Medical, Inc., part of Johnson & Johnson MedTech and a global leader in the field of circulatory restoration, has announced that data from 23 company-sponsored and funded studies, including three late-breaking presentations, will be presented at EuroPCR 2025, May 20-23 in Paris. These studies will feature data from Shockwave’s cardiovascular portfolio, including its market-leading Shockwave Intravascular Lithotripsy (IVL) platform and innovative Reducer technology that are transforming the treatment of cardiovascular disease.1

May 14, 2025 — BrightHeart, a provider of artificial intelligence (AI) solutions for pediatric cardiology and obstetrics, recently announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its second device, B-Right Views.

May 8, 2025 — Nancy Brown, chief executive officer of the American Heart Association, has been named to TIME’s 2025 TIME100 Health, a list recognizing the 100 most influential individuals in health. The full list and related tributes appear in the May 26, 2025 issue of TIME, available on newsstands on May 16, and now at time.com/time100health. 

May 12, 2025 — GE HealthCare recently unveiled Signa Sprint, an FDA 510(k) pending

May 5, 2025 — The TCT Geoffrey O. Hartzler Master Operator Award will be presented to Kenneth Rosenfield, MD, MSc, during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT will take place Oct. 25-28, 2025, in San Francisco, California. The award is given each year to a physician who has advanced the field of interventional cardiovascular medicine through technical excellence and leadership.

May 3, 2025 — The Society for Cardiovascular Angiography & Interventions (SCAI) announced its new leadership for 2025–26, with Srihari S. Naidu, MD, MSCAI, assuming the role of president during SCAI Scientific Sessions 2025, held May 1–3 in Washington, D.C.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now